KHK2898
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KHK2898, covering 2017-03-16 to 2017-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors [Phase 1]